An announcement from Qiagen ( (QGEN) ) is now available.
Qiagen N.V. announced a manager’s transaction involving Eva Pisa, a member of the administrative or supervisory body, who was granted 5,990 Restricted Stock Units. This transaction, linked to the exercise of share option programs, reflects the company’s ongoing efforts to align managerial interests with shareholder value, potentially impacting its market perception and stakeholder confidence.
More about Qiagen
Qiagen N.V. operates in the biotechnology industry, focusing on providing sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is known for its products and services that enable customers to gain valuable insights from the building blocks of life, DNA, RNA, and proteins.
YTD Price Performance: -13.75%
Average Trading Volume: 1,094,687
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.36B
See more insights into QGEN stock on TipRanks’ Stock Analysis page.